130209-78-8 Usage
Derived from
Prostaglandin F2α, a naturally occurring lipid molecule in the body.
Modified with
16-phenoxy and isopropyl ester groups.
Purpose of modifications
Increased stability and potency.
Potential pharmaceutical use
Treatment of glaucoma.
Mechanism of action
Decreases intraocular pressure.
Veterinary use
Induction of parturition in livestock.
Current status
Under investigation, with further research needed to understand its full therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 130209-78-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,2,0 and 9 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 130209-78:
(8*1)+(7*3)+(6*0)+(5*2)+(4*0)+(3*9)+(2*7)+(1*8)=88
88 % 10 = 8
So 130209-78-8 is a valid CAS Registry Number.
130209-78-8Relevant articles and documents
Synthesis of (±) travoprost and its analogs
Mudduluru, Harikrishna,Hindupur, Rama M.,Dubey, Pramod K.,Madhavaram, Shankar,Tatini, Lakshmikumar,Subbaraju, Gottumukkala V.
experimental part, p. 234 - 241 (2012/04/18)
A new synthetic approach for the antiglaucoma agent, travoprost (1) has been developed in four steps from key intermediate (2). Key transformations include Horner-Wadsworth-Emmons reaction and separation of diastereomers to obtain (±) travoprost (1) and its analogs.
